Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Therapeutic modalities in 2012 (n = 104)

From: Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study

Pharmacological prophylaxis women and men women men
tranexamic acid 10 6 (10 %) 4 (8 %)
danazol 26 13 (23 %) 13 (27 %
IRT    
pd C1 - INH 9 7 (12 %) 2 (4 %)
Therapy of acute attacks    
Icatibant 12 9 (16 %) 3 (6 %)
pd C1 – INH 57 32 (56 %) 25 (53 %)
  1. Percentages are related in women to the total amount of women, in men to the total amount of men